Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Sonodynamic Therapy With 5-ALA for the Treatment of Recurrent Glioblastoma Using Neuronavigation-Guided Low-Intensity Focused Ultrasound

NCT06039709 is registered in ClinicalTrials.gov with Shayan Moosa, MD as lead sponsor.

NCT NCT06039709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Sonodynamic Therapy With 5-ALA for the Treatment of Recurrent Glioblastoma Using Neuronavigation-Guided Low-Intensity Focused Ultrasound
Lead sponsor
Shayan Moosa, MD
Phase
Phase 1
Overall status
Recruiting
Start date
January 31, 2024
Completion date
June 30, 2027
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbm, glioblastoma multiforme, recurrent glioblastoma